J Endourol

• 

  Publication Venue For

  • Benchtop Assessment of a New Single-Use Flexible Ureteroscope. 2020
  • Study to Enhance Understanding of Stent-Associated Symptoms: Rationale and Study Design. 2020
  • Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement..  34:1103-1110. 2020
  • Editorial Comment on: "The Impact of Patient, Procedural, and Staffing Factors Upon Ureteroscopy Cost" by Alsyouf et al..  34:752. 2020
  • Holmium:Yttrium-Aluminum-Garnet Laser Pulse Type Affects Irrigation Temperatures in a Benchtop Ureteral Model..  33:896-901. 2019
  • The Rise and Fall of High Temperatures During Ureteroscopic Holmium Laser Lithotripsy..  33:794-799. 2019
  • Nationwide Readmission Rates Following Percutaneous Nephrolithotomy: Does Age Matter?.  33:704-711. 2019
  • Low Dose Fluoroscopy During Ureteroscopy Does Not Compromise Surgical Outcomes..  33:527-532. 2019
  • Avoiding a Lemon: Performance Consistency of Single-Use Ureteroscopes..  33:127-131. 2019
  • Let's Get to the Point: Comparing Insertion Characteristics and Scope Damage of Flat-Tip and Ball-Tip Holmium Laser Fibers..  33:22-26. 2019
  • Dusting Efficiency of the Moses Holmium Laser: An Automated In Vitro Assessment..  32:1131-1135. 2018
  • Antibiotic Utilization Before Endourological Surgery for Urolithiasis: Endourological Society Survey Results..  32:978-985. 2018
  • Predictors of Rectourethral Fistula Formation After Primary Whole-Gland Cryoablation for Prostate Cancer: Results from the Cryo On-Line Database Registry..  32:791-796. 2018
  • Editorial Comment on: Outpatient Percutaneous Nephrolithotomy: The UC San Diego Health Experience by Bechis et al..  32:402. 2018
  • Technique of Percutaneous Nephrolithotomy..  32:S17-S27. 2018
  • Evaluation and Comparison of Contemporary Energy-Based Surgical Vessel Sealing Devices..  32:329-337. 2018
  • Effect of Laser Settings and Irrigation Rates on Ureteral Temperature During Holmium Laser Lithotripsy, an In Vitro Model..  32:59-63. 2018
  • Next-Generation Single-Use Ureteroscopes: An In Vitro Comparison..  31:1301-1306. 2017
  • Randomized Controlled Trial Comparing Three Different Modalities of Lithotrites for Intracorporeal Lithotripsy in Percutaneous Nephrolithotomy..  31:1145-1151. 2017
  • Comparison of Radiation Exposure from Fixed Table Fluoroscopy to a Portable C-Arm During Ureteroscopy..  31:835-840. 2017
  • Imaging Advances in Urolithiasis..  31:623-629. 2017
  • Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data..  31:564-571. 2017
  • Comparison of Broad vs Narrow Focal Width Lithotripter Fields..  31:502-509. 2017
  • Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation..  31:497-501. 2017
  • Evaluation of a Novel Single-Use Flexible Ureteroscope. 2017
  • Benchtop and Initial Clinical Evaluation of the ShockPulse Stone Eliminator in Percutaneous Nephrolithotomy..  31:191-197. 2017
  • Comparison of the Nanopulse Lithotripter to the Holmium Laser: Stone Fragmentation Efficiency and Impact on Flexible Ureteroscope Deflection and Flow..  30:1150-1154. 2016
  • Contemporary Management of Struvite Stones Using Combined Endourologic and Medical Treatment: Predictors of Unfavorable Clinical Outcome..  30:771-777. 2016
  • Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen..  30:624-631. 2016
  • Definitive Management of Failure After Pyeloplasty..  30 Suppl 1:S23-S27. 2016
  • Digital Tomosynthesis: A Viable Alternative to Noncontrast Computed Tomography for the Follow-Up of Nephrolithiasis?.  30:366-370. 2016
  • Prevalence of Hyperoxaluria in Urinary Stone Formers: Chronological and Geographical Trends and a Literature Review..  30:469-475. 2016
  • Evaluation of Novel Ball-Tip Holmium Laser Fiber: Impact on Ureteroscope Performance and Fragmentation Efficiency..  30:189-194. 2016
  • Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry..  30:43-48. 2016
  • Radiation Dosimetry for Ureteroscopy Patients: A Phantom Study Comparing the Standard and Obese Patient Models..  30:57-62. 2016
  • Contemporary Practice Patterns of Flexible Ureteroscopy for Treating Renal Stones: Results of a Worldwide Survey..  29:1221-1230. 2015
  • Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population..  29:1193-1198. 2015
  • Symptomatic subcapsular and perinephric hematoma following ureteroscopic lithotripsy for renal calculi..  29:277-282. 2015
  • Clinical outcomes after ureteroscopic lithotripsy in patients who initially presented with urosepsis: matched pair comparison with elective ureteroscopy..  28:1439-1443. 2014
  • Accuracy of endoscopic intraoperative assessment of urologic stone size..  28:582-586. 2014
  • Radiation exposure in the follow-up of patients with urolithiasis comparing digital tomosynthesis, non-contrast CT, standard KUB, and IVU..  27:1187-1191. 2013
  • Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics..  27:1102-1106. 2013
  • Ureteral stents for impassable ureteroscopy..  27:549-553. 2013
  • Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer..  27:288-293. 2013
  • The administration of renoprotective agents extends warm ischemia in a rat model..  27:343-348. 2013
  • In-vitro assessment of a new portable ballistic lithotripter with percutaneous and ureteroscopic models..  26:1500-1505. 2012
  • Mn porphyrins as novel molecular magnetic resonance imaging contrast agents..  26:1420-1424. 2012
  • Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience..  26:1361-1366. 2012
  • Optical performance comparison of deflectable laparoscopes for laparoendoscopic single-site surgery..  26:1340-1345. 2012
  • Laparoscopic anatrophic nephrolithotomy: developments of the technique in the era of minimally invasive surgery..  26:444-450. 2012
  • Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma..  26:566-573. 2012
  • Organ-specific radiation dose rates and effective dose rates during percutaneous nephrolithotomy..  26:439-443. 2012
  • Apical surgical margins status in robot-assisted laparoscopic radical prostatectomy does not depend on disease characteristics..  26:361-365. 2012
  • Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure?.  26:330-335. 2012
  • Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents..  1420-1424. 2011
  • The clinical research office of the endourological society audit committee..  25:1811-1813. 2011
  • Ex-vivo ureteroscopy at the time of live donor nephrectomy..  25:1405-1409. 2011
  • Optimization of treatment strategy used during shockwave lithotripsy to maximize stone fragmentation efficiency..  25:1507-1511. 2011
  • Pathologic evaluation of hemostatic agents in percutaneous nephrolithotomy tracts in a porcine model..  25:1353-1357. 2011
  • Renal function outcomes after laparoscopic renal cryoablation..  25:1287-1291. 2011
  • Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy..  25:563-567. 2011
  • The digital flexible ureteroscope: in vitro assessment of optical characteristics..  25:519-522. 2011
  • Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma..  25:377-384. 2011
  • Heterogeneity in the reporting of disease characteristics and treatment outcomes in studies evaluating treatments for nephrolithiasis..  24:1411-1414. 2010
  • Contemporary results of focal therapy for prostate cancer using cryoablation..  24:827-834. 2010
  • Prostate biopsy in selecting candidates for hemiablative focal therapy..  24:849-853. 2010
  • Prostate cancer: an evolving paradigm..  24:805-809. 2010
  • Localized amyloidosis of the upper urinary tract: a case series of three patients managed with reconstructive surgery or surveillance..  24:641-644. 2010
  • Dual-energy computed tomography with advanced postimage acquisition data processing: improved determination of urinary stone composition..  24:347-354. 2010
  • Long-term results of percutaneous nephrolithotomy: does prophylactic medical stone management make a difference?.  23:1773-1776. 2009
  • NOTES: Education and training..  23:813-819. 2009
  • Minimal contamination of the human peritoneum after transvesical incision..  23:659-663. 2009
  • High definition laparoscopy: objective assessment of performance characteristics and comparison with standard laparoscopy..  23:523-528. 2009
  • Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor..  22:2433-2439. 2008
  • Success of laser endoureterotomy of ureteral strictures associated with ureteral stones is related to stone impaction..  22:2507-2511. 2008
  • Robot-assisted ureterolysis, retroperitoneal biopsy, and omental wrap: pilot series for the treatment of idiopathic retroperitoneal fibrosis..  22:1669-1675. 2008
  • The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma..  22:1617-1621. 2008
  • Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis..  22:1359-1366. 2008
  • Use of the Escape nitinol stone retrieval basket facilitates fragmentation and extraction of ureteral and renal calculi: a pilot study..  22:1213-1217. 2008
  • Practice patterns of ureteral stenting after routine ureteroscopic stone surgery: A survey of practicing urologists.  21:1287-1291. 2007
  • Focal therapy for prostate and renal cancer--are we ready for it?.  24:663. 2010